MUMBAI, India, April 25 -- Intellectual Property India has published a patent application (202517033446 A) filed by Seagen Inc., Bothell, U.S.A., on April 4, for 'antibodies that bind cd228.'
Inventor(s) include Heiser Ryan; Scherer Erin; and Sandall Sharsti.
The application for the patent was published on April 25, under issue no. 17/2025.
According to the abstract released by the Intellectual Property India: "The disclosure provides antibodies or antigen binding fragments thereof specific for CD228. Such antibodies or antigen binding fragments can be used in many pharmaceutical applications for example as anti cancer agents and/or immune modulators. The present disclosure also concerns methods of making the antibodies or antigen bindin...